ALX3 rs10800638: Facial Features and Nose Bridge Variation
The genetic variant rs10800638 is a single-nucleotide polymorphism located in a regulatory enhancer region associated with the ALX3 gene. Genome-wide association studies have identified statistical correlations between this marker and normal-range facial morphology, particularly nose bridge width and prominence. Because facial shape is a complex polygenic trait influenced by hundreds of genetic loci and developmental factors, the evidence linking this individual variant to visible features is classified as limited.
What each genotype means
Typical facial profile association
This genotype is associated with specific variations in nose bridge width and prominence as identified in genome-wide association studies. These findings reflect normal human facial morphological variation rather than a medical condition. As this is a complex trait influenced by many genetic and environmental factors, this genotype alone does not determine your facial appearance.
This genotype is common in many populations, with a minor allele frequency of approximately 0.42 in admixed Latin American cohorts and 0.25 in European populations.
Typical facial profile association
This genotype is associated with specific variations in nose bridge width and prominence as identified in genome-wide association studies. These findings reflect normal human facial morphological variation rather than a medical condition. As this is a complex trait influenced by many genetic and environmental factors, this genotype alone does not determine your facial appearance.
This genotype is common in many populations, with a minor allele frequency of approximately 0.42 in admixed Latin American cohorts and 0.25 in European populations.
Typical facial profile association
This genotype is associated with specific variations in nose bridge width and prominence as identified in genome-wide association studies. These findings reflect normal human facial morphological variation rather than a medical condition. As this is a complex trait influenced by many genetic and environmental factors, this genotype alone does not determine your facial appearance.
This genotype is common in many populations, with a minor allele frequency of approximately 0.42 in admixed Latin American cohorts and 0.25 in European populations.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism rs10800638 is situated on human chromosome 1 in close proximity to the ALX3 gene. Rather than altering an amino acid sequence directly within a protein-coding exon, this variant resides in a non-coding regulatory element known as an enhancer. Enhancers act as molecular switches that control when, where, and to what degree neighboring genes are transcribed into messenger RNA during organismal development. Functional genomics and chromatin mapping indicate that this region interacts with the transcriptional machinery governing midfacial patterning. The major alleles observed at rs10800638 involve an exchange between cytosine (C) and thymine (T). Because regulatory variants typically tweak gene expression levels rather than eliminating gene function entirely, the biological effects of rs10800638 are subtle and tissue-specific, primarily manifesting during embryonic craniofacial morphogenesis.
Biological Role of the ALX3 Gene
The ALX3 gene encodes the ALX homeobox 3 transcription factor, a DNA-binding protein vital for developmental biology. ALX homeobox transcription factors guide spatial organization and cell fate determination during early embryonic life. In vertebrate models and human genetic studies, ALX3 is known for its role in frontonasal and cranial neural crest cell differentiation. These specialized neural crest cells migrate into the embryonic facial prominences to form the underlying skeletal and cartilage structures of the nose, forehead, and upper jaw. Rare, severe loss-of-function mutations in ALX3 disrupt normal developmental fusion and midline patterning, leading to congenital conditions such as frontorhiny. Common regulatory variants like rs10800638 do not cause clinical malformations; instead, they modestly adjust ALX3 expression within normal physiological thresholds, nudging the biological processes that sculpt everyday facial diversity.
Research Associations and Evidence Strength
Genome-wide association studies (GWAS) focused on craniofacial features have implicated rs10800638 in human facial morphology, especially variations in the midface. Specifically, population analyses have detected associations between this marker and quantitative three-dimensional measurements of the nose bridge, including its breadth, projection, and prominence. However, the overall strength of evidence for this single variant is categorized as limited. Facial features are classic quantitative, complex polygenic traits. Hundreds of independent loci—including well-documented developmental genes like PAX3, PRDM16, and GLI3—collectively influence facial dimensions, with each single locus explaining only a tiny fraction of the total phenotypic variance. Furthermore, association signals can vary depending on cohort ancestries and the 3D imaging techniques used, meaning that an individual's rs10800638 genotype alone cannot reliably predict midfacial anatomy.
Population Frequency and Diversity
Allele frequencies for rs10800638 show notable variation across diverse geographic and ancestral populations. In admixed Latin American cohorts, the minor allele frequency (MAF) is relatively high, reaching approximately 0.42. In contrast, among individuals of European ancestry, the minor allele frequency is noticeably lower, recorded at around 0.25. Similar gradients in allele distribution are commonly observed across genetic markers influencing craniofacial diversity and physical traits, reflecting ancestral demographic history, genetic drift, and localized evolutionary pressures. Because allele frequencies fluctuate substantially between continents and ancestral backgrounds, genetic studies evaluating facial variation emphasize the importance of using ethnically diverse, well-characterized cohorts to ensure that observed associations reflect genuine developmental biology rather than underlying population stratification.
Understanding Your Results: What You Can and Cannot Do
Discovering your genotype at rs10800638 provides a fascinating glimpse into the genetics of normal human diversity, but it is important to place these findings in perspective. This variant is not a diagnostic marker or a health hazard; it carries no known clinical risk for disease, facial clefting, or craniofacial syndromes. Moreover, consumer DNA tests reporting an individual's rs10800638 genotype cannot construct an accurate facial composite or predict the exact contours of someone's nose. Because midfacial development is polygenic, non-additive, and influenced by prenatal environment and biomechanical forces, rs10800638 represents merely one minor note in an elaborate biological symphony. Learning your genotype serves solely as an educational exploration of developmental genetics and human variation.
How common is this variant?
The minor allele frequency for rs10800638 is approximately 0.42 in admixed Latin American cohorts and approximately 0.25 in populations of European ancestry.
Frequently asked questions
Can rs10800638 predict what my nose will look like?
No. While rs10800638 has been statistically linked to differences in nose bridge width and prominence across large study populations, its individual effect size is tiny. Facial features are shaped by hundreds of genes alongside developmental factors, making individual prediction impossible from a single marker.
Does having the rs10800638 variant cause any medical problems?
No. The rs10800638 variant is an enhancer polymorphism associated solely with standard physical variation within healthy populations. It does not cause congenital malformations, breathing difficulties, or any craniofacial disorders.
Why does ALX3 affect facial features?
ALX3 encodes a homeobox transcription factor essential for guiding embryonic neural crest cells as they develop into the bones and cartilage of the midface. Subtle differences in how this gene is expressed can gently modify the physical dimensions of facial structures during early embryonic growth.
Why do allele frequencies for rs10800638 differ between populations?
Like many genetic markers associated with physical traits, rs10800638 frequencies vary across global populations due to human migration history, random genetic drift, and localized evolutionary pressures over tens of thousands of years.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10800638?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29